In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).
Open accessAbstract
Glycoprotein G (gG) of equine herpesvirus type 1 (EHV-1), a structural component of virions and secreted from virus-infected cells, was shown to bind to a variety of different chemokines and as such might be involved in immune modulation. Little is known, however, about its role in the replication cycle and infection of EHV-1 in vivo. Here we report on the function of gG in context of virus infection in vitro and in vivo. A gG deletion mutant of pathogenic EHV-1 strain RacL11 (vL11DeltagG) was constructed and analyzed. Deletion of gG had virtually no effect on the growth properties of vL11DeltagG in cell culture when compared to parental virus or a rescuant virus vL11DeltagGR, respectively, and virus titers and plaque formation were unaffected in the absence of the glycoprotein. Similarly, in the murine model of EHV-1 infection, no significant differences in virulence between the gG deletion mutant and RacL11 or vL11DeltagGR were found at high doses of infection. However, infection of mice at lower doses revealed that the gG deletion mutant was able to replicate to higher titers in lungs of infected mice. Additionally, these mice lost significantly more weight than those infected with RacL11 and a more pronounced inflammatory response in lungs was observed. Therefore we concluded that deletion of gG in EHV-1 seems to lead to an exacerbation of respiratory disease in the mouse.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In vivo, an EHV-1 gG deleted mutant induces a more pronounced inflammatory response compared to the wild-type virus.
“In vivo, an EHV-1 gG deleted mutant induces a more pronounced inflammatory response compared to the wild-type virus (von Einem et al., 2007).”
From The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1 (2021) · cites this paper as von Einem et al., 2007
In “Absence of gG exacerbates respiratory disease at lower doses of infection” (page not provided), the paper reports greater lung inflammation with the gG-deleted virus than with parental RacL11 at lower infection doses. It also reports no difference at a high dose, a qualification the citing sentence omits. (LLM, conf=0.90)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589 · see citing works
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684 · see citing works
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.
Datsenko, K., & Wanner, B. (2000) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.120163297 · Cited by 15,902 · see citing works
Kyhse‐Andersen, J. (1984) · Journal of Biochemical and Biophysical Methods · doi:10.1016/0165-022x(84)90040-x · Cited by 2,505 · see citing works
Lee, E.-C., Yu, D., de Velasco, J. M., Tessarollo, L., Swing, D. A., Court, D. L., Jenkins, N. A., & Copeland, N. G. (2001) · Genomics · doi:10.1006/geno.2000.6451 · Cited by 1,179 · see citing works
The DNA sequence of equine herpesvirus-1
Telford, E. A. R., Watson, M. S., McBride, K. R., & Davison, A. J. (1992) · Virology · doi:10.1016/0042-6822(92)90706-u · Cited by 650 · see citing works
Rapid modification of bacterial artificial chromosomes by ET- recombination
Muyrers, J. P. P. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.6.1555 · Cited by 534 · see citing works
The MHC class I antigen presentation pathway: strategies for viral immune evasion
Hewitt, E. W. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01738.x · Cited by 491 · see citing works
Patel, J., & Heldens, J. G. M. (2004) · The Veterinary Journal · doi:10.1016/j.tvjl.2004.04.018 · Cited by 287 · see citing works
Balan, P., Davis-Poynter, N. J., Bell, S., Atkinson, H., Browne, H. M., & Minson, T. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-6-1245 · Cited by 241 · see citing works
Graham, K., Lalani, A. S., Macen, J., Ness, T. L., Barry, M., Liu, L.-Y., Lucas, A. R., Clark‐Lewis, I., Moyer, R. W., & McFadden, G. (1997) · Virology · doi:10.1006/viro.1996.8423 · Cited by 215 · see citing works
A Broad Spectrum Secreted Chemokine Binding Protein Encoded by a Herpesvirus
Parry, C. M., Simas, J. P., Smith, V. P., Stewart, C. A., Minson, A. C., Efstathiou, S., & Alcamı́, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.573 · Cited by 210 · see citing works
Molecular virology of ruminant herpesviruses
Schwyzer, M., & Ackermann, M. (1996) · Veterinary Microbiology · doi:10.1016/s0378-1135(96)01231-x · Cited by 172 · see citing works
Bryant, N. A., Davis‐Poynter, N., Vanderplasschen, A., & Alcami, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg092 · Cited by 141 · see citing works
Rapid Identification of Nonessential Genes of Herpes Simplex Virus Type 1 by Tn5 Mutagenesis
Weber, P. C., Levine, M., & Glorioso, J. C. (1987) · Science · doi:10.1126/science.3033824 · Cited by 128 · see citing works
Modulating chemokines: more lessons from viruses
Lalani, A. S., Barrett, J. W., & McFadden, G. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01556-x · Cited by 119 · see citing works
Bridgeman, A., Stevenson, P. G., Simas, J. P., & Efstathiou, S. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.301 · Cited by 99 · see citing works
Kaashoek, M. J., Rijsewijk, F. A. M., Ruuls, R. C., Keli, G. M., Thiry, É., Pastoret, P.-P., & van Oirschot, J. T. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00269-7 · Cited by 91 · see citing works
Evolutionary relationships of virion glycoprotein genes in the S regions of alphaherpesvirus genomes
McGeoch, D. J. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-10-2361 · Cited by 89 · see citing works
Glycoprotein G is a virulence factor in infectious laryngotracheitis virus
Devlin, J. M., Browning, G. F., Hartley, C. A., Kirkpatrick, N. C., Mahmoudian, A., Noormohammadi, A. H., & Gilkerson, J. R. (2006) · Journal of General Virology · doi:10.1099/vir.0.82194-0 · Cited by 88 · see citing works
van Berkel, V. H., Levine, B., Kapadia, S. B., Goldman, J. E., Speck, S. H., & Virgin, H. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14358 · Cited by 84 · see citing works
Rudolph, J., O’Callaghan, D. J., & Osterrieder, N. (2002) · Journal of Veterinary Medicine Series B · doi:10.1046/j.1439-0450.2002.00534.x · Cited by 81 · see citing works
Demmin, G. L., Clase, A. C., Randall, J. A., Enquist, L. W., & Banfield, B. W. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10856-10869.2001 · Cited by 72 · see citing works
Rudolph, J., & Osterrieder, N. (2002) · Virology · doi:10.1006/viro.2001.1277 · Cited by 71 · see citing works
Secreted poxvirus chemokine binding proteins
Lalani, A. S., & McFadden, G. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.570 · Cited by 67 · see citing works
Tran, L. C., Kissner, J., Westerman, L. E., & Sears, A. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.020510297 · Cited by 58 · see citing works
Alterations in the Equine Herpesvirus Type-1 (EHV-1) Strain RacH During Attenuation
Hübert, P. H., Birkenmaier, S., Rziha, H. ‐., & Osterrieder, N. (1996) · Journal of Veterinary Medicine Series B · doi:10.1111/j.1439-0450.1996.tb00282.x · Cited by 57 · see citing works
Colle, C. F., Flowers, C. C., & O’Callaghan, D. J. (1992) · Virology · doi:10.1016/0042-6822(92)90509-n · Cited by 57 · see citing works
Rudolph, J., Seyboldt, C., Granzow, H., & Osterrieder, N. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2952-2963.2002 · Cited by 51 · see citing works
Osterrieder, N., Neubauer, A., Brandmüller, C., Kaaden, O., & O’Callaghan, D. J. (1996) · Virology · doi:10.1006/viro.1996.0652 · Cited by 50 · see citing works
Viral chemokine-modulatory proteins: tools and targets
Boomker, J. M., de Leij, L. F. M. H., THE, T. H., & Harmsen, M. C. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.12.002 · Cited by 42 · see citing works
Trapp, S., Osterrieder, N., Keil, G. M., & Beer, M. (2003) · Journal of General Virology · doi:10.1099/vir.0.18682-0 · Cited by 40 · see citing works
Lybarger, L. P., Wang, X., Harris, M., & Hansen, T. H. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.11.009 · Cited by 40 · see citing works
Neubauer, A., Beer, M., Brandmüller, C., Kaaden, O., & Osterrieder, N. (1997) · Virology · doi:10.1006/viro.1997.8857 · Cited by 39 · see citing works
von Einem, J., Wellington, J. E., Whalley, J. M., Osterrieder, K., O’Callaghan, D. J., & Osterrieder, N. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3003-3013.2004 · Cited by 38 · see citing works
Smith, P. M., Zhang, Y.-F., Grafton, W. D., Jennings, S., & O'Callaghan, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10034-10040.2000 · Cited by 34 · see citing works
Equine Herpesvirus 1 (EHV-1) Glycoprotein M: Effect of Deletions of Transmembrane Domains
Seyboldt, C., Granzow, H., & Osterrieder, N. (2000) · Virology · doi:10.1006/viro.2000.0664 · Cited by 31 · see citing works
Smith, P. M., Kahan, S. M., Rorex, C. B., von Einem, J., Osterrieder, N., & O’Callaghan, D. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5105-5115.2005 · Cited by 31 · see citing works
Nakamichi, K., Matsumoto, Y., & Otsuka, H. (2002) · Virology · doi:10.1006/viro.2001.1264 · Cited by 30 · see citing works
Frampton, A. R., Smith, P. M., Zhang, Y., Matsumura, T., Osterrieder, N., & O’Callaghan, D. J. (2002) · Virus Research · doi:10.1016/s0168-1702(02)00245-9 · Cited by 30 · see citing works
Structural and Antigenic Identification of the ORF12 Protein (αTIF) of Equine Herpesvirus 1
Lewis, J. B., Thompson, Y. G., Feng, X., Holden, V. R., O’Callaghan, D. J., & Caughman, G. B. (1997) · Virology · doi:10.1006/viro.1997.8477 · Cited by 29 · see citing works
Drummer, H. E., Crabb, B. S., & Studdert, M. J. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-5-1205 · Cited by 26 · see citing works
Mettenleiter, T. C., Kern, H., & Rauh, I. (1990) · Virology · doi:10.1016/0042-6822(90)90324-k · Cited by 25 · see citing works
Synthesis and Processing of the Equine Herpesvirus 1 Glycoprotein M
Osterrieder, N., Neubauer, A., Fakler, B., Brandmüller, C., Seyboldt, C., Kaaden, O., & Baines, J. D. (1997) · Virology · doi:10.1006/viro.1997.8561 · Cited by 25 · see citing works
Transcriptional analyses of the unique short segment of EHV-1 strain Kentucky A
Colle, C. F., & O’Callaghan, D. J. (1995) · Virus Genes · doi:10.1007/bf01702881 · Cited by 24 · see citing works
Bovine herpesvirus 1 glycoprotein G is required for viral growth by cell-to-cell infection
Nakamichi, K., Ohara, K., Kuroki, D., & Otsuka, H. (2000) · Virus Research · doi:10.1016/s0168-1702(00)00171-4 · Cited by 20 · see citing works
Nakamichi, K., Kuroki, D., Matsumoto, Y., & Otsuka, H. (2001) · Virology · doi:10.1006/viro.2000.0740 · Cited by 20 · see citing works
Osterrieder, N., Seyboldt, C., & Elbers, K. (2001) · Veterinary Microbiology · doi:10.1016/s0378-1135(01)00357-1 · Cited by 18 · see citing works
Meyer, H. E., & Hübert, P. H. (1988) · Veterinary Microbiology · doi:10.1016/0378-1135(88)90119-8 · Cited by 17 · see citing works
Huang, J., Hartley, C. A., Ficorilli, N., Crabb, B. S., & Studdert, M. J. (2005) · Archives of Virology · doi:10.1007/s00705-005-0607-9 · Cited by 11 · see citing works
Colle, C. F., & O’Callaghan, D. J. (1996) · Virology · doi:10.1006/viro.1996.0330 · Cited by 7 · see citing works
Flagged first, then by citations
1 of the 52 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Day, L., 1999. Characterisation of selected glycoproteins of equine herpesvirus- 1: immune in the murine model. PhD thesis. University of Leeds, UK.
- Osterrieder, N., Kaaden, O.R., 1999. Structure and function of equine herpesvirus glycoproteins -a review. Proceedings of the 8th International Conference on Equine Infectious Diseases. R&W Publications, Newmarket, UK, pp. 111-118.
Cited by
Sorted by citations
Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.
Hussey, G. S., Hussey, S. B., Wagner, B., Horohov, D. W., Van de Walle, G. R., Osterrieder, N., Goehring, L. S., Rao, S., & Lunn, D. P. (2011) · Veterinary Research · doi:10.1186/1297-9716-42-23 · Cited by 73 · see citing works
Self-citationDevlin, J. M., Viejo‐Borbolla, A., Browning, G. F., Noormohammadi, A. H., Gilkerson, J. R., Alcamı́, A., & Hartley, C. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.013 · Cited by 63 · see citing works
Chemokine binding proteins: An immunomodulatory strategy going viral
González-Motos, V., Kropp, K. A., & Viejo‐Borbolla, A. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.007 · Cited by 61 · see citing works
“Deletion of gG results in increased EHV-1 pathogenicity in an intranasal mouse model of infection [90].”
The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1
Laval, K., Poelaert, K. C. K., Van Cleemput, J., Zhao, J., Vandekerckhove, A. P., Gryspeerdt, A. C., Garré, B., van der Meulen, K., Baghi, H. B., Dubale, H. N., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.662686 · Cited by 54 · see citing works
“In vivo, an EHV-1 gG deleted mutant induces a more pronounced inflammatory response compared to the wild-type virus (von Einem et al., 2007).”
BackgroundVan de Walle, G. R., Peters, S. T., VanderVen, B. C., O'Callaghan, D. J., & Osterrieder, N. (2008) · Journal of Virology · doi:10.1128/jvi.00868-08 · Cited by 54 · see citing works
“determined exactly as previously described (45).”
MethodInfluentialVan de Walle, G. R., May, M. L., Sukhumavasi, W., von Einem, J., & Osterrieder, N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4161 · Cited by 55 · see citing works
Azab, W., & Osterrieder, N. (2012) · Journal of Virology · doi:10.1128/jvi.06555-11 · Cited by 49 · see citing works
Self-citationImmune modulation by virus-encoded secreted chemokine binding proteins
Heidarieh, H., Hernáez, B., & Alcamı́, A. (2015) · Virus Research · doi:10.1016/j.virusres.2015.02.028 · Cited by 47 · see citing works
Osterrieder, N., & Van de Walle, G. R. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.02.010 · Cited by 46 · see citing works
Viejo‐Borbolla, A., Munoz, A., Tabarés, E., & Alcamı́, A. (2009) · Journal of General Virology · doi:10.1099/vir.0.011940-0 · Cited by 42 · see citing works
“Deletion of gG from the EHV-1 genome results in increased pathogenicity in mice (von Einem et al., 2007) and correlates with a higher neutrophil migration into the lungs, indicating a role for EHV-1-gG in chemotaxis inhibition in vivo (Van de Walle et al., 2007).”
BackgroundZebra-borne equine herpesvirus type 1 (EHV-1) infection in non-African captive mammals
Abdelgawad, A., Azab, W., DAMIANI, A. M., Baumgartner, K., Will, H., Osterrieder, N., & Greenwood, A. D. (2013) · Veterinary Microbiology · doi:10.1016/j.vetmic.2013.12.011 · Cited by 41 · see citing works
Vandekerckhove, A. P., Glorieux, S., Gryspeerdt, A. C., Steukers, L., Van Doorsselaere, J., Osterrieder, N., Van de Walle, G. R., & Nauwynck, H. J. (2011) · Veterinary Microbiology · doi:10.1016/j.vetmic.2011.03.038 · Cited by 38 · see citing works
“Indeed, the 279 pathogenesis of an infection with EHV-1 strain RacL11 in the explant model closely 280 resembles the situation in the natural host, whereas the clinical picture in the mouse model is 281 much more dramatic (von Einem et al., 2007).”
Backgroundde Walle, G. R. V., May, M. L., Peters, S., Metzger, S. M., Rosas, C. T., & Osterrieder, N. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.123 · Cited by 37 · see citing works
Holz, C. L., Nelli, R. K., Wilson, M. E., Zarski, L. M., Azab, W., Baumgardner, R., Osterrieder, N., Pease, A., Zhang, L., Hession, S., et al. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000773 · Cited by 34 · see citing works
“Cell lysates were heated at 95 C for 5min and proteins were separated by 12% SDS-PAGE as described previously [70].”
MethodThird International Havemeyer Workshop on Equine Herpesvirus type 1
Kydd, J. H., Slater, J. D., Osterrieder, N., Lunn, D. P., Antczak, D. F., Azab, W., Balasuriya, U. B. R., Barnett, C., Brosnahan, M. M., Cook, C., et al. (2012) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.2012.00604.x · Cited by 33 · see citing works
Effective Treatment of Respiratory Alphaherpesvirus Infection Using RNA Interference
Fulton, A., Peters, S., Perkins, G. A., Jarosinski, K. W., DAMIANI, A. M., Brosnahan, M. M., Buckles, E. L., Osterrieder, N., & de Walle, G. R. V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004118 · Cited by 33 · see citing works
“All animal experiments were performed in accordance with the U.S. Animal Welfare Act, under the supervision of Cornell University's Animal Care and Use Committee, and were conducted as previously described with some modifications [30] .”
Influentialde Walle, G. R. V., Sakamoto, K., & Osterrieder, N. (2007) · Journal of Virology · doi:10.1128/jvi.02137-07 · Cited by 33 · see citing works
“In our study, however, all wild-type BL/6 mice showed clinical signs typical of EHV-1 infection, such as weight loss, ruffled fur, and hunched posture, and the signs were similar to those observed in the well-established BALB/c mouse model (25, 26).”
BackgroundMethodResultInfluentialAlphaherpesviruses and Chemokines: Pas de Deux Not Yet Brought to Perfection
de Walle, G. R. V., Jarosinski, K. W., & Osterrieder, N. (2008) · Journal of Virology · doi:10.1128/jvi.00098-08 · Cited by 28 · see citing works
Said, A., Azab, W., DAMIANI, A. M., & Osterrieder, N. (2012) · Journal of Virology · doi:10.1128/jvi.00891-12 · Cited by 27 · see citing works
“(PAGE) exactly as described before (83).”
MethodSpiesschaert, B., Osterrieder, N., & Azab, W. (2015) · Viruses · doi:10.3390/v7020522 · Cited by 24 · see citing works
“004% bromophenol blue) was added to lysates, the mixture was heated at 95 °C for 5 min, and proteins were separated by 10% SDS-polyacrylamide gel electrophoresis (PAGE) as described before [46].”
Azab, W., Zajic, L. B., & Osterrieder, N. (2012) · Veterinary Research · doi:10.1186/1297-9716-43-61 · Cited by 19 · see citing works
“004% bromophenol blue) was added, the mixture was heated at 95 °C for 5 min and proteins were separated by 10% SDS-polyacrylamide gel electrophoresis (PAGE) exactly as previously described [35].”
Methodde Walle, G. R. V., Kaufer, B. B., Chbab, N., & Osterrieder, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808127200 · Cited by 17 · see citing works
Thormann, N., de Walle, G. R. V., Azab, W., & Osterrieder, N. (2012) · Virus Research · doi:10.1016/j.virusres.2012.07.029 · Cited by 14 · see citing works
Poelaert, K. C. K., Cleemput, J. V., Laval, K., Xie, J., Favoreel, H. W., & Nauwynck, H. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001317 · Cited by 10 · see citing works
Said, A., & Osterrieder, N. (2013) · Virology · doi:10.1016/j.virol.2013.11.035 · Cited by 9 · see citing works
Said, A., DAMIANI, A. M., & Osterrieder, N. (2014) · Virology · doi:10.1016/j.virol.2014.05.009 · Cited by 8 · see citing works
Spiesschaert, B., Stephanowitz, H., Krause, E., Osterrieder, N., & Azab, W. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000418 · Cited by 5 · see citing works
“Sample buffer [1 M Tris/HCl (pH 6.8), 0.8 % SDS, 0.4 % glycerol, 0.15 % b-mercaptoethanol, 0.004 % bromophenol blue] was added, the mixture was heated at 95 uC for 5 min and proteins were separated by 10 % SDSPAGE as described before (von Einem et al., 2007).”
MethodInfluentialChemokine-binding proteins encoded by herpesviruses
Benko, M., Lenhartová, S., Kempová, V., Betáková, T., & Kúdelová, M. (2020) · Acta Virologica · doi:10.4149/av_2020_213 · Cited by 4 · see citing works
Equine Herpesvirus Infections: Treatment Progress and Challenges in Horses and Donkeys
Khan, M. Z., Ji, Y., Fan, X., Liu, Y., Liu, W., & Wang, C. (2025) · Veterinary Sciences · doi:10.3390/vetsci12111082 · Cited by 5 · see citing works
“Deletion studies of gG demonstrate enhanced inflammatory responses and increased immune cell migration to infected sites [86,186].”
Losinno, A. D., Vissani, M. A., Sanchez, D., & DAMIANI, A. M. (2023) · Archives of Virology · doi:10.1007/s00705-023-05727-4 · Cited by 2 · see citing works
Gulati, B. R., Virmani, N., & Tripathi, B. N. (2019) · Springer eBooks · doi:10.1007/978-981-13-9073-9_4 · Cited by 1 · see citing works
Regulatory Strategies and Factors Affecting Veterinary Viral Vector Development
Bublot, M., Woerly, V., Wang, Q., & King, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-51927-8_13 · Cited by 1 · see citing works
Chemokines and Viral Infections
Alcamı́, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14013-5 · Cited by 1 · see citing works
Said, A. (2013) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10249
Profiling Chemokine–Glycoprotein G Interactions: Implications for Alphaherpesviral Immune Evasion
de Walle, G. R. V., & Osterrieder, N. (2012) · Future Virology · doi:10.2217/fvl.12.31
Functions of glycoprotein G of herpes simplex virus type 2
Görander, S. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University)
- Authors
- von Einem, J., Smith, P. M., Van de Walle, G. R., O'Callaghan, D. J., & Osterrieder, N.
- Affiliations
- Louisiana State University (US)
- Cornell University (US)
- Corresponding author
- Osterrieder, Nikolaus
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 362
- Issue
- 1
- Pages
- 151-162
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2063071600
- Cited by
- 37
- References
- 52
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 3 · 2012: 5
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Virology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- equine herpesvirus 1, glycoprotein G, chemokine binding, viral virulence, respiratory diseases, immunomodulation, mouse infection model, inflammation
- MeSH terms
- Animals, Body Weight, Cell Line, Disease Models, Animal, Herpesvirus 1, Equid, Female, Herpesviridae Infections, Histocytochemistry, Lung, Mice, Inbred BALB C, Microscopy, Viral Plaque Assay, Rabbits, Viral Envelope Proteins, Virulence, Gene Deletion, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review